1. Home
  2. IRON vs AMPX Comparison

IRON vs AMPX Comparison

Compare IRON & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$70.54

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Amprius Technologies Inc.

AMPX

Amprius Technologies Inc.

HOLD

Current Price

$17.76

Market Cap

2.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
AMPX
Founded
2017
2008
Country
United States
United States
Employees
N/A
109
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
AMPX
Price
$70.54
$17.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
7
Target Price
$103.18
$20.17
AVG Volume (30 Days)
356.5K
7.2M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$76.15
Revenue Next Year
$283.52
$61.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.20
$1.97
52 Week High
$99.50
$19.76

Technical Indicators

Market Signals
Indicator
IRON
AMPX
Relative Strength Index (RSI) 64.18 56.20
Support Level $57.79 $10.00
Resistance Level $82.70 $19.76
Average True Range (ATR) 2.83 1.60
MACD 1.07 -0.08
Stochastic Oscillator 96.13 72.18

Price Performance

Historical Comparison
IRON
AMPX

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About AMPX Amprius Technologies Inc.

Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. Its silicon anodes are a direct drop-in replacement of the graphite anode in traditional lithium-ion batteries, and its manufacturing processes leverage the manufacturing processes for conventional lithium-ion batteries and the related supply chain.

Share on Social Networks: